Adherence to oseltamivir guidelines during influenza pandemic, the Netherlands.
Identifieur interne : 000D39 ( PubMed/Curation ); précédent : 000D38; suivant : 000D40Adherence to oseltamivir guidelines during influenza pandemic, the Netherlands.
Auteurs : Esther H. Fietjé ; Daphne Philbert ; Erica C G. Van Geffen ; Nina A. Winters ; Marcel L. BouvySource :
- Emerging infectious diseases [ 1080-6059 ] ; 2012.
Descripteurs français
- KwdFr :
- Adhésion aux directives, Adolescent, Adulte, Adulte d'âge moyen, Antiviraux (usage thérapeutique), Enquêtes et questionnaires, Femelle, Grippe humaine (traitement médicamenteux), Grippe humaine (épidémiologie), Guides de bonnes pratiques cliniques comme sujet, Humains, Jeune adulte, Mâle, Oséltamivir (usage thérapeutique), Pandémies, Pays-Bas (épidémiologie).
- MESH :
- traitement médicamenteux : Grippe humaine.
- usage thérapeutique : Antiviraux, Oséltamivir.
- épidémiologie : Grippe humaine, Pays-Bas.
- Adhésion aux directives, Adolescent, Adulte, Adulte d'âge moyen, Enquêtes et questionnaires, Femelle, Guides de bonnes pratiques cliniques comme sujet, Humains, Jeune adulte, Mâle, Pandémies.
- Wicri :
- geographic : Pays-Bas.
English descriptors
- KwdEn :
- Adolescent, Adult, Antiviral Agents (therapeutic use), Female, Guideline Adherence, Humans, Influenza, Human (drug therapy), Influenza, Human (epidemiology), Male, Middle Aged, Netherlands (epidemiology), Oseltamivir (therapeutic use), Pandemics, Practice Guidelines as Topic, Surveys and Questionnaires, Young Adult.
- MESH :
- chemical , therapeutic use : Antiviral Agents, Oseltamivir.
- geographic , epidemiology : Netherlands.
- drug therapy : Influenza, Human.
- epidemiology : Influenza, Human.
- Adolescent, Adult, Female, Guideline Adherence, Humans, Male, Middle Aged, Pandemics, Practice Guidelines as Topic, Surveys and Questionnaires, Young Adult.
DOI: 10.3201/eid1803.111351
PubMed: 22377063
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000D39
Links to Exploration step
pubmed:22377063Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Adherence to oseltamivir guidelines during influenza pandemic, the Netherlands.</title><author><name sortKey="Fietje, Esther H" sort="Fietje, Esther H" uniqKey="Fietje E" first="Esther H" last="Fietjé">Esther H. Fietjé</name></author><author><name sortKey="Philbert, Daphne" sort="Philbert, Daphne" uniqKey="Philbert D" first="Daphne" last="Philbert">Daphne Philbert</name></author><author><name sortKey="Van Geffen, Erica C G" sort="Van Geffen, Erica C G" uniqKey="Van Geffen E" first="Erica C G" last="Van Geffen">Erica C G. Van Geffen</name></author><author><name sortKey="Winters, Nina A" sort="Winters, Nina A" uniqKey="Winters N" first="Nina A" last="Winters">Nina A. Winters</name></author><author><name sortKey="Bouvy, Marcel L" sort="Bouvy, Marcel L" uniqKey="Bouvy M" first="Marcel L" last="Bouvy">Marcel L. Bouvy</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="RBID">pubmed:22377063</idno><idno type="pmid">22377063</idno><idno type="doi">10.3201/eid1803.111351</idno><idno type="wicri:Area/PubMed/Corpus">000D39</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000D39</idno><idno type="wicri:Area/PubMed/Curation">000D39</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000D39</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Adherence to oseltamivir guidelines during influenza pandemic, the Netherlands.</title><author><name sortKey="Fietje, Esther H" sort="Fietje, Esther H" uniqKey="Fietje E" first="Esther H" last="Fietjé">Esther H. Fietjé</name></author><author><name sortKey="Philbert, Daphne" sort="Philbert, Daphne" uniqKey="Philbert D" first="Daphne" last="Philbert">Daphne Philbert</name></author><author><name sortKey="Van Geffen, Erica C G" sort="Van Geffen, Erica C G" uniqKey="Van Geffen E" first="Erica C G" last="Van Geffen">Erica C G. Van Geffen</name></author><author><name sortKey="Winters, Nina A" sort="Winters, Nina A" uniqKey="Winters N" first="Nina A" last="Winters">Nina A. Winters</name></author><author><name sortKey="Bouvy, Marcel L" sort="Bouvy, Marcel L" uniqKey="Bouvy M" first="Marcel L" last="Bouvy">Marcel L. Bouvy</name></author></analytic><series><title level="j">Emerging infectious diseases</title><idno type="eISSN">1080-6059</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Antiviral Agents (therapeutic use)</term><term>Female</term><term>Guideline Adherence</term><term>Humans</term><term>Influenza, Human (drug therapy)</term><term>Influenza, Human (epidemiology)</term><term>Male</term><term>Middle Aged</term><term>Netherlands (epidemiology)</term><term>Oseltamivir (therapeutic use)</term><term>Pandemics</term><term>Practice Guidelines as Topic</term><term>Surveys and Questionnaires</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adhésion aux directives</term><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Antiviraux (usage thérapeutique)</term><term>Enquêtes et questionnaires</term><term>Femelle</term><term>Grippe humaine (traitement médicamenteux)</term><term>Grippe humaine (épidémiologie)</term><term>Guides de bonnes pratiques cliniques comme sujet</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Oséltamivir (usage thérapeutique)</term><term>Pandémies</term><term>Pays-Bas (épidémiologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term><term>Oseltamivir</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Netherlands</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term><term>Oséltamivir</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term><term>Pays-Bas</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Female</term><term>Guideline Adherence</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Pandemics</term><term>Practice Guidelines as Topic</term><term>Surveys and Questionnaires</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adhésion aux directives</term><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Enquêtes et questionnaires</term><term>Femelle</term><term>Guides de bonnes pratiques cliniques comme sujet</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Pandémies</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Pays-Bas</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22377063</PMID><DateCompleted><Year>2012</Year><Month>07</Month><Day>11</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1080-6059</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>3</Issue><PubDate><Year>2012</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Emerging infectious diseases</Title><ISOAbbreviation>Emerging Infect. Dis.</ISOAbbreviation></Journal><ArticleTitle>Adherence to oseltamivir guidelines during influenza pandemic, the Netherlands.</ArticleTitle><Pagination><MedlinePgn>534-5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3201/eid1803.111351</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fietjé</LastName><ForeName>Esther H</ForeName><Initials>EH</Initials></Author><Author ValidYN="Y"><LastName>Philbert</LastName><ForeName>Daphne</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>van Geffen</LastName><ForeName>Erica C G</ForeName><Initials>EC</Initials></Author><Author ValidYN="Y"><LastName>Winters</LastName><ForeName>Nina A</ForeName><Initials>NA</Initials></Author><Author ValidYN="Y"><LastName>Bouvy</LastName><ForeName>Marcel L</ForeName><Initials>ML</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Emerg Infect Dis</MedlineTA><NlmUniqueID>9508155</NlmUniqueID><ISSNLinking>1080-6040</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>20O93L6F9H</RegistryNumber><NameOfSubstance UI="D053139">Oseltamivir</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019983" MajorTopicYN="Y">Guideline Adherence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053139" MajorTopicYN="N">Oseltamivir</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22377063</ArticleId><ArticleId IdType="doi">10.3201/eid1803.111351</ArticleId><ArticleId IdType="pmc">PMC3309585</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Antimicrob Agents Chemother. 2006 Jul;50(7):2395-402</Citation><ArticleIdList><ArticleId IdType="pubmed">16801417</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Control Hosp Epidemiol. 2009 Apr;30(4):370-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19236284</ArticleId></ArticleIdList></Reference><Reference><Citation>Ned Tijdschr Geneeskd. 2009;153:A1053</Citation><ArticleIdList><ArticleId IdType="pubmed">19857317</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2009 Sep;9(9):537-45</Citation><ArticleIdList><ArticleId IdType="pubmed">19665930</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2009 Mar 11;301(10):1034-41</Citation><ArticleIdList><ArticleId IdType="pubmed">19255110</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D39 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000D39 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:22377063
|texte= Adherence to oseltamivir guidelines during influenza pandemic, the Netherlands.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:22377063" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a PandemieGrippaleV1
| This area was generated with Dilib version V0.6.34. |  |